Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer

International Journal of Obesity

Volumn 25, Issue 2, 2001, Pages 296-298

  Nguyen, M C ^a   Stewart, R B ^a   Banerji, M A ^a   Gordon, D H ^b   Kral, J G ^a  

^a SUNY Downstate Medical Center   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Computed tomography; Fatty liver; Metabolic syndrome X; Visceral adipose tissue

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BODY FAT; BODY MASS; BREAST CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID STORAGE; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; BODY COMPOSITION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ESTROGEN ANTAGONISTS; FATTY LIVER; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; OBESITY; TAMOXIFEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035131855     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801488     Document Type: Article

References (12)

1. Tamoxifen in the treatment of breast cancer
2. Fatal hyperlipemia in a case of metastatic breast cancer treated by tamoxifen
3. Delayed severe triglyceridemia from tamoxifen
4. Tamoxifen-associated hepatocellular damage and agranulocytosis
5. Tamoxifen-associated steatohepatitis - Report of three cases
6. Fatty livers in breast carcinoma patients on tamoxifen
7. Tamoxifen-induced fatty liver in patients with breast cancer
8. Body fat topography as an independent predictor of fatty liver
9. Liver pathology and the metabolic syndrome X in severe obesity
10. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer
11. Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer
12. Body fat distribution and breast cancer in the Framingham Study